CompanyDeals

ImmuneOnco Biopharmaceuticals Begins Trading on HKEX with Successful IPO

CompanyDrug

Sihuan Pharmaceutical’s Birociclib NDA Accepted for Review by China’s NMPA

CompanyDeals

Bloomage Biotech Terminates Joint Venture with Medytox Inc. for Botulinum Toxin Development

CompanyDrug

Jointown Medical’s COVID-19 Drug Candidate SHEN211 Accepted for Review by NMPA

CompanyDrug

Hansoh Pharmaceutical Receives NMPA Approval for Generic Ofev (Nintedanib)

CompanyDeals

Pilot Gene Technology Secures $13.8 Million in Series B Financing for Diagnostic Expansion

CompanyDrug

Chia Tai Tianqing’s Generic Entresto Approved by NMPA, Launch Expected in 2026

CompanyDrug

Novo Nordisk’s Esperoct on Track for Priority Review in Hemophilia A Treatment

CompanyDrug

Bayer Subsidiary’s Parkinson’s Treatment Bemdaneprocel Shows Promise in Phase I

CompanyDrug

AstraZeneca’s Calquence Approved by NMPA for Chronic Lymphocytic Leukemia Treatment

CompanyDrug

Roche’s Alecensa Achieves Milestone in Adjuvant Therapy Trial for Early-Stage NSCLC

CompanyDeals

Amgen and Horizon Therapeutics Reach Agreement with FTC to Proceed with Acquisition